Hepatocellular Cancer Active Not Recruiting Phase 1 Trials for Sorafenib (DB00398)

Also known as: Cancer, Hepatocellular

IndicationStatusPhase
DBCOND0037277 (Hepatocellular Cancer)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02292173Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular CancerTreatment